ArticleAnnals of the rheumatic diseases2019

Are the loading dose treatment groups superior to the 150 mg without loading dose group in the secukinumab FUTURE 5 study?

Bernardo Matos da CunhaPubMed ↗Publisher ↗

No numbers read from the abstract.